Changing Physician Behavior in Ordering Digoxin Assays

Abstract

Spanish

French

OBJECTIVE:

TO assess the ability to modify physicians' use of serum digoxin assays in a sustained fashion through (1) an educational intervention by a clinical pharmacist, and (2) changes in the computerized medical information system.

DESIGN:

A before/after methodology was used to compare test use by hospital staff physicians in two phases. Phase 1 was an educational intervention conducted by a clinical pharmacist with an 8-month follow-up. Phase 2 was a medical information system intervention with a 12-month follow-up.

PATIENTS:

Adult inpatients from July 1990 through December 1993 who received either digoxin therapy or at least one serum digoxin assay.

MAIN OUTCOME MEASURE:

Digoxin assays per patient day while receiving digoxin (assays/digoxin day), in-hospital mortality, and length of stay were compared before and after implementation of the interventions.

RESULTS:

A total of 9468 patients received a digoxin and/or serum digoxin assay. Baseline use of serum digoxin assays was 0.178 assays/digoxin day. Following phase 1, the educational intervention, use declined 20.2% to 0.142 assays/digoxin day (p < 0.03). After phase 2, the implementation of changes in the medical information system, digoxin assay use was maintained at 16.3% less than that at baseline (p < 0.03). Patient mortality was unaffected.

CONCLUSIONS:

A low-intensity educational intervention by a clinical pharmacist supplemented by medical information system modification resulted in an important decrease in the use of digoxin assays. The change in physician behavior was sustained for more than 18 months. The model presented is not labor intensive, does not require continuous maintenance by healthcare personnel for a sustained effect, and may be widely applicable to healthcare providers.

Get full access to this article

View all access options for this article.

References

Greco

Eisenberg

. Changing physicians' practices. N Engl J Med 1993; 329: 1271–4.

Leape

Brennan

Laird

Lawthers

Localio

Barnes

. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study H. N Engl J Med 1991; 324: 377–84.

Epstein

. Changing physician behavior, increasing challenges for the 1990s. Arch Intern Med 1991; 151: 2147–9.

Berwick

. Peer review and quality management: are they compatible? Qual Rev Bull 1990; 16: 246–51.

Lomas

. Words without action? The production, dissemination, and impact of consensus recommendations. Annu Rev Public Health 1991; 12: 41–65.

Lomas

Enkin

Anderson

Hannah

Vayda

Singer

. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA 1991; 265: 2202–7.

McNeil

Pederson

Gatsonis

. Current issues in profiling: potentials and limitations. In: Physician Payment Review Commission Conference on Profiling. No. 92–2. Washington, DC: Physician Payment Review Commission, 1992: 46–70.

Tierney

Miller

McDonald

. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N Engl J Med 1990; 322: 1499–504.

Keller

Soule

Wennberg

Hanley

. Dealing with geographic variations in the use of hospitals: the experience of the Maine Medical Assessment Foundation Orthopedic Study Group. J Bone Joint Surg 1990; 72A: 1286–93.

10.

Soumerai

Avorn

. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA 1991; 263: 549–56.

11.

Erban

Kinman

Schwartz

. Routine use of the prothrombin and partial thromboplastin times. JAMA 1989; 262: 2428–32.

12.

Klamerus

Munger

. Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoring. Am J Hosp Pharm 1988; 45: 1887–93.

13.

Wing

Duff

. Impact of a therapeutic drug monitoring program for digoxin. Arch Intern Med 1987; 147: 1405–8.

14.

Michalko

Blain

. An evaluation of a clinical pharmacokinetic service for serum digoxin levels. Ther Drug Monit 1987; 9: 311–9.

15.

Voluntary Hospitals of America Clinical/Financial Information System. Irving, TX: Voluntary Hospitals of America, 1994.

16.

Proc GLM. SAS Institute, Cary, NC, 1989.

17.

Warren

McBean

Hass

Babish

. Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Arch Intern Med 1994; 154: 1482–7.

18.

Kemon

Castellsague

Perlman

Ostfeld

. Incidence of hospitalization for digitalis toxicity among elderly Americans. Am J Med 1994; 96: 426–31.

19.

Smith

. Digitalis: mechanisms of action and clinical use. N Engl J Med 1988; 318: 358–65.

20.

Bedell

Deitz

Leeman

Delbanco

. Incidence and characteristics of preventable iatrogenic cardiac arrests. JAMA 1991; 265: 2815–20.

21.

Duhme

Greenblatt

Koch-Weser

. Reduction of digoxin toxicity associated with measurement of serum levels: a report from the Boston Collaborative Drug Surveillance Program. Ann Intern Med 1974; 80: 516–9.

22.

Lewis

. Clinical use of serum digoxin concentrations. Am J Cardiol 1992; 69: 976–1076.

23.

Kelly

Smith

. Use and misuse of digitalis blood levels. Heart Dis Stroke 1992; 1: 117–22.

24.

Aronson

Hardman

. Digoxin. BMJ 1992; 305: 1149–52.

25.

Soumerai

Ross-Degnan

Avom

McLaughlin

Choodnovskoy

. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325: 1072–7.

26.

Salem-Schatz

Avorn

Soumerai

. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. JAMA 1990; 264: 471–5.